CardiologyMonthly gene-silencing jab fails to cut events in stiff hearts
In the CARDIO-TTRansform trial, monthly eplontersen lowered the faulty TTR protein but did not significantly reduce heart deaths and events in amyloid cardiomyopathy over 140 weeks.
28 August 2026